Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Infections such as dengue and Japanese encephalitis are important problems in Laos but confirmed data are lacking, particularly from outside the capital Vientiane. Rapid diagnostic tests that can be kept at tropical room temperature help better diagnosis and treatment, and also inform policy to implement vaccination programmes.

I’m Audrey Dubot-Pérès, I’m a virologist from IRD (Institut de Recherche pour le Développement) and I am based in Marseille at the Unit of Emerging Viruses at the Faculty of Medicine, and I am supervising the virology activity in LOMWUR in Laos.

Dengue virus infection is an important problem in Laos, with infections all year round and epidemics during the rainy season. The most serious epidemic was in 2013 with more than 40,000 reported cases and 95 deaths. These are not only in urban areas but there is also evidence of dengue infections in rural areas. Few data are available; some investigation are developing and we hope that we can provide more data in the future, especially from provinces.

The lack of confirmed data is a problem, we need to have accurate data based on confirmed laboratory testing. It’s a problem because the facilities are only in the Vientiane capital, so we have most of the data coming from the capital. There is a lack of data especially from the rural areas and the provinces. We don’t have a whole picture of what’s happening in the country and it’s really limited to the capital with some data from some provinces.

In Marseille we have a diagnosis platform where we develop and validate the molecular testing, like real time PCR. We developed a format, which is a freeze-dried format that we can send at room temperature to Laos. All the different testing for the different viruses are in the same format, so this is really easy to use for the team in Laos. We also provide some quality control so we can control the results in Laos.

We are involved in viruses that are important problems in Laos, which include dengue virus and also the viruses that cause central nervous system infections. We did a long term study on this and we set up diagnosis services at Mahosot Hospital. We provide support for diagnosis on central nervous system infections and arboviruses. The main arboviruses causes encephalitis – the Japanese encephalitis virus – and our studies provided the first data on the incidence of Japanese encephalitis in Laos. This was key information for the implementation of vaccination in Laos.

For me the most significant advances in our research was the development of new innovative technology for pathogen detection and characterisation, for example RDTs (Rapid Diagnostic Tests) that are easy to use and don’t require laboratory facilities. They are of important added value because they can be used in the community, in rural areas. However, they need to be validated in the environmental and epidemiological context they will be used. This is what we did for dengue RDT and we showed that it remains efficient even after long term storage at tropical temperature.

I think that our research matters because we are studying infectious diseases that can be fatal; some are preventable and our work in fact could save lives. I will give an example: in the framework of this study we set up a cerebrospinal diagnosis service at Mahosot Hospital; we did the first diagnosis of herpes simplex encephalitis on a young kid who could receive the appropriate treatment and survived. I would say that our research is in fact driven by translational medicine because we are studying the causes of infectious diseases in Laos, to adapt diagnosis and treatment, and to inform policy in Laos to decrease infectious diseases burden. The Japanese encephalitis data that we provided were key information to implement vaccination. Many other things need to be discovered in Laos and we know only a small part of the picture and there is plenty of research that needs to be done in Laos and not only in Vientiane capital.

Audrey is affiliated with IRD (Institut de Recherche pour le Développement), Unité des Virus Émergents (UVE: Aix-Marseille Univ – IRD 190 – Inserm 1207 – IHU Méditerranée Infection), Marseille, France.

affiliates

Audrey Dubot-Peres

Dr Audrey Dubot-Peres is Head of Virology in LOMWRU (Laos PDR) where viral infections (Japanese encephalitis, dengue, acute respiration infection, gastro-enteritis, hand foot and mouth disease) represent a major public health burden and important challenge for patient management.

The program “Viral infections of medical importance in Laos” is conducted in collaboration with the IRD (Institut de Recherche pour le Développement), Unité des Virus Émergents (UVE), Marseille, France.

More podcasts related to Global Health

Mike English: Health services that deliver for newborns

Basic hospital care may be key to saving newborn lives. Professor Mike English outlines a multidisciplinary project engaging policy-makers and practitioners in Kenya. This project demonstrated poor coverage of Nairobi’s 4.25 million population if a sick newborn baby needs quality hospital care. Using novel research approaches the team also identified how severe shortages of nurses contribute to poor quality of care for patients and negatively affect nurses themselves.

Tran Hien: Infectious diseases in the tropics

Although incidence of malaria has decreased in Vietnam, the burden of infectious diseases remains high and weighs heavily on the health care system. Clinical research aims to allow investments to go further: findings in the laboratory, tested in clinical trials and then applied to the community, help improve diagnosis and management.

Ronald Geskus: Sophisticated biostatistics for complex clinical research

The role of biostatisticians in clinical research is to contribute to trial design, by calculating sample size for example, and to help draw correct conclusions from the data, discriminating important information from noise. They are instrumental in the translation of a practical problem into a statistical model, and the translation of the result into practice.

Rogier Van Doorn: Research at OUCRU Hanoi

Antibiotics are widely used in Vietnam, leading to widespread antimicrobial resistance. Monitoring antibiotic use helps inform the government to change treatment guidelines and implement antibiotic stewardship programmes. This may also prevent the transmission of resistant bacteria outside the country.

Heiman Wertheim: Clinical research in low and middle-income countries

Drug resistant infections are a global crisis and we cannot focus on our own country only. Clinical trials in low and middle income countries where the burden is highest, as well as work with local communities and engagement with policy makers help influence public health policies.

Guy Thwaites: Tuberculosis meningitis

Tuberculosis meningitis affects a fractions of TB patients but causes high levels of mortality and morbidity. A recent trial at OUCRU showed that aspirin can greatly improve outcomes. Such trial is typical of the work done in our Vietnam units, where all the research is focussed on improving the outcome for patients directly.

Motiur Rahman: OUCRU laboratory management

OUCRU laboratories provide support to the unit’s extensive clinical research programme, from level 2 laboratory to SAPO 4 laboratory for high-risk pathogens responsible for zoonotic infections. Early diagnosis and detection of antimicrobial resistance helps prescribe the right medicine in time, contributing to better patient management.

Raph Hamers: Developing collaborative clinical trials in Indonesia

Indonesia is a very populous country with a huge burden of infectious diseases such as TB, malaria, HIV and CNS infections. Running clinical trials requires high levels of expertise, currently developed and strengthened by institutions such as IOCRL (Universities of Indonesia and Oxford Clinical Research laboratory). Better collaborations will also help great ideas make a bigger impact.

Jeremy Day: Central nervous system and HIV infections in Vietnam

Brain infections such as meningitis and encephalitis are highly debilitating diseases, and an accurate diagnostic is essential to give patients the best treatment available. For cryptococcal meningitis, clinical trials focus on prevention, for an early diagnosis, and novel ways to use existing treatments or repurpose old drugs.

Abhilasha Karkey: Connecting research with communities in Nepal

Antimicrobial resistance is a huge burden in Nepal, particularly in hospitals where many nosocomial infections are caused by resistant pathogens. With limited resources, little infection controls and proper guidelines in place, finding out the main risk factors helps reduce infection rates within a hospital and better target vaccination campaigns.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.